Diadem announces U.S. Licensing Agreement with Quest Diagnostics for Alzheimer's Disease Prognostic

Rachel Ougier Simonin
Nov 6, 2023
1 min read

https://www.biospace.com/article/releases/diadem-spa-announces-exclusive-u-s-licensing-agreement-with-quest-diagnostics-for-its-alzosure-predict-alzheimer-s-disease-prognostic-technology/

Recent Posts

See All

Listen & Learn - Me, AI and your job application

LISTEN & LEARN: BIOPHARMACEUTICAL PRODUCT FORECASTING

Please find enclosed the slides created by Robert F. Siegmund for our Listen & Learn on product forecasting.

Listen & Learn: Foresight

Please find enclosed the Foresight L&L presentation, brought to our community by our HCD member Antonis Sarlikiotis.

Comentarios